Connect with us
🔹 Man who rates benches on Instagram finally finds his 10/10 🔹 British couple on honeymoon killed in helicopter crash on Greek island 🔹 Wetherspoons bans customers playing music from phones in pubs 🔹 Officers told not to pursue car on wrong side of motorway before crash, says Ireland's police body 🔹 Snooker player Graeme Dott goes on trial over child abuse allegations

Uncategorized

Veos Pharmaceuticals Unveils ThymoTropin™ to Support Muscle Health and Preservation During Weight Loss and Aging Journeys

Published

on

Veos Pharmaceuticals, a leading innovator with a portfolio of nearly 40 products across the EU, US, and Canada, today announced the launch of ThymoTropin™, a revolutionary over-the-counter (OTC) solution for muscle growth, repair, and preservation. ThymoTropin™, powered by clinically validated thymol and carvacrol, is the first product of its kind targeting myostatin regulation, a crucial mechanism for maintaining muscle mass and performance.

As part of Veos Pharma’s commitment to delivering science-backed innovations, ThymoTropin™ addresses the unique needs of individuals experiencing muscle loss due to aging, chronic disease, or weight management regimens, including GLP-1 treatments and calorie-restricted diets.

Filling a Critical Gap in Muscle Health

More than 50% of individuals undergoing weight loss or battling chronic illnesses face muscle loss, impacting their mobility, strength, and overall health. ThymoTropin™ is formulated to counteract this decline by preserving and enhancing muscle mass through its innovative dual-action mechanism:

  • Clinically proven myostatin regulation for targeted muscle preservation.
  • Support for lean muscle growth and endurance, validated through preclinical and clinical studies.

“At Veos Pharmaceuticals, we are committed to addressing critical health gaps with effective, science-driven solutions,” said Dr. Bassam Damaj, Executive Chairman of Veos Pharma. “ThymoTropin™ is a game-changer in muscle health, offering proven benefits for individuals managing muscle loss while aligning with modern health goals, including weight loss and ageing-related care.”

Clinically Backed, Patented Innovation

ThymoTropin™ is supported by a robust patent portfolio, including:

  • US Patent No. 11,135,178: Enhancing Muscle Growth via Monoterpenes
  • CA Patent No. 2,964,239: Applications of Monoterpenes in Muscle Health
  • EP Patent No. 3191086: Monoterpene Formulations for Muscle Enhancement
  • PT Patent No. 3191086: Monoterpenes for Myostatin Regulation

Clinical results demonstrate up to a 50% increase in muscle mass and a 37% improvement in endurance. ThymoTropin™’s unique focus on myostatin regulation differentiates it from traditional protein supplements, making it a superior solution for muscle health.

Targeted Nutrition for Growing Market Needs

The global market for muscle health and repair products continues to grow, driven by increasing demand from aging populations, oncology patients, and fitness-conscious individuals. ThymoTropin™ directly addresses these needs by providing:

  • Muscle preservation during weight loss
  • Enhanced recovery and repair
  • Support for aging-related muscle decline

In a competitive landscape dominated by protein supplements like Abbott’s Protality™ and Nestle Boost, ThymoTropin™ stands out with its clinically validated myostatin regulation mechanism. Unlike traditional products, ThymoTropin™ offers targeted efficacy without unnecessary calories or sugars, making it an ideal solution for modern health-conscious consumers.

Growing Market Opportunity and Competitive Landscape

The global muscle health and nutritional support market are projected to exceed $15 billion by 2025, driven by increasing demand from ageing populations, oncology-supportive care, and weight management solutions. Competitor products such as Abbott’s Protality™ and Nestle Boost™ have collectively generated impressive sales, with:

  • Protality™ generates an estimated annual revenue of $300 million and a 15% market share.
  • Nestle Boost® generates an estimated $500 million annually with a 25% market share.
  • Traditional whey protein supplements lead with over $8 billion in annual revenue and a dominant 60% market share.

While competitor products focus on general protein supplementation, ThymoTropin™ sets itself apart by targeting myostatin regulation, offering a precise and effective solution for muscle growth and preservation without unnecessary calories or sugars.

Available as an Ingredient for B2B Applications

ThymoTropin™ is offered as a premium ingredient for business-to-business (B2B) formulations. This enables manufacturers in the health, nutrition, and functional food sectors to incorporate ThymoTropin™’s proven myostatin-targeting benefits into their products, meeting growing consumer demand for advanced muscle health solutions. Veos Pharma partners with businesses to provide customized solutions and ensure seamless integration into existing product lines.

About Veos Pharmaceuticals

Headquartered in Madrid, Spain, Veos Pharmaceuticals is a global leader in health innovation with a portfolio of nearly 40 products across the EU, US, and Canada. The company specializes in OTC solutions, biostimulants, and advanced nutritional products aimed at improving quality of life. Veos Pharma’s flagship products include Ocufresh®, BioPropello™, OleoSorb™, VEOX-Preserv™, and ThymoTropin™.

For more information, contact:

Dr. Bassam Damaj
Executive Chairman
Veos Pharmaceuticals, SL
Email: [email protected]
Website: www.veospharma.com

Protality™ is a trademark of Abbott Laboratories. Boost® is a trademark of Nestlé

References:

www.grandviewresearch.com/industry-analysis/sports-supplement-market

Nestlé, S.A. (SWX: NESN) disclosures and Abbott Laboratories (NYSE: ABT) disclosures

Forward-Looking Statements: This press release may contain forward-looking statements that involve risks and uncertainties. Veos Pharmaceuticals assumes no obligation to update or revise these statements after the date of publication.

The post Veos Pharmaceuticals Unveils ThymoTropin™ to Support Muscle Health and Preservation During Weight Loss and Aging Journeys appeared first on Pinion Newswire.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Richard Bennett on Quantitative Investing

ALBANY, New York  Richard Bennett, a financial markets research and investment strategy professional, continues to focus on quantitative investment research, macroeconomic analysis, asset allocation, portfolio construction, and risk management. As financial markets become increasingly influenced by global economic conditions, capital flows, technology, and rapidly expanding datasets, Bennett believes that investment research requires a more structured and multidimensional […]

Published

on

Richard Bennett, a financial markets research and investment strategy professional, continues to focus on quantitative investment research, macroeconomic analysis, asset allocation, portfolio construction, and risk management.

As financial markets become increasingly influenced by global economic conditions, capital flows, technology, and rapidly expanding datasets, Bennett believes that investment research requires a more structured and multidimensional analytical process. His approach emphasizes the combination of market data, macroeconomic indicators, quantitative models, valuation analysis, and risk controls to better understand changing market environments.

Rather than relying primarily on short-term market forecasts, Richard Bennett focuses on evaluating the broader forces that may influence asset prices over time.

These can include economic growth, inflation trends, interest-rate conditions, market liquidity, corporate fundamentals, investor positioning, and changes in capital allocation across different sectors and asset classes.

This research framework reflects a broader investment philosophy centered on disciplined analysis and risk awareness.

A Data-Driven Approach to Market Research

One of Richard Bennett’s primary areas of interest is the use of quantitative analysis to support financial market research.

Modern markets generate large amounts of economic, corporate, trading, and behavioral data. Bennett views this information as most useful when it is organized within a clear analytical framework rather than considered in isolation.

Quantitative indicators can help researchers identify patterns, compare historical market environments, evaluate relative valuations, and monitor changes in momentum, volatility, liquidity, and investor behavior.

At the same time, Bennett believes quantitative models should not be treated as substitutes for broader market understanding. Instead, they can be used alongside fundamental and macroeconomic research to provide additional context and improve the consistency of investment analysis.

By combining different sources of information, investors may be better positioned to distinguish between short-term market noise and more meaningful changes in economic or financial conditions.

Understanding Market Cycles

Market-cycle analysis is another important component of Richard Bennett’s research interests.

Financial markets do not operate under a single set of conditions. Different periods can be characterized by expansion, slowing growth, rising inflation, declining inflation, changes in monetary policy, shifts in liquidity, or increasing market uncertainty.

These conditions can influence sectors, asset classes, and investment styles in different ways.

For this reason, Bennett emphasizes the importance of evaluating portfolios within the context of the broader economic and market environment.

A strategy that performs effectively under one set of conditions may behave differently when interest rates, volatility, economic growth, or investor risk appetite changes. Understanding these relationships can therefore play an important role in portfolio construction and strategic asset allocation.

Market-cycle research can also help investors develop more flexible investment frameworks rather than relying on fixed assumptions about future market behavior.

Risk Management as Part of the Investment Process

Richard Bennett also places significant emphasis on risk management.

In his view, investment analysis should not focus exclusively on identifying potential returns. It should also consider the risks associated with market volatility, concentration, correlation, liquidity, and changing economic conditions.

A disciplined risk-management framework can include diversification, position sizing, portfolio monitoring, scenario analysis, and the evaluation of how different assets

may respond to unexpected market developments.

This approach is particularly relevant during periods of elevated uncertainty, when relationships between asset classes can change quickly and traditional assumptions may become less reliable.

Bennett believes that effective portfolio management requires an ongoing balance between opportunity and risk. As market conditions evolve, investment strategies may need to be reviewed and adjusted rather than remaining static.

Quantitative Research and Portfolio Construction

Quantitative research can also play an important role in portfolio construction.

Richard Bennett’s areas of interest include the analysis of multiple factors that may influence investment performance, such as valuation, momentum, quality, volatility, earnings trends, and broader macroeconomic conditions.

By examining several variables together, researchers can develop a more comprehensive view of potential opportunities and risks.

This type of analysis can also support portfolio optimization by helping investors evaluate how individual positions interact within a broader portfolio.

Instead of looking at each investment independently, portfolio analysis considers factors such as diversification, correlation, volatility, and overall exposure to different market drivers.

For Bennett, this broader perspective is an important part of disciplined investment strategy.

Artificial Intelligence and the Future of Investment Research

Another area Richard Bennett continues to follow is the development of artificial intelligence and financial technology.

Artificial intelligence is increasingly being explored across financial markets for applications involving data analysis, pattern recognition, research automation, risk monitoring, and information processing.

Bennett is particularly interested in how AI-based technologies may complement traditional investment research.

Financial analysts today have access to significantly more information than in previous decades. Economic data, company disclosures, market prices, news, alternative datasets, and quantitative indicators can create an enormous volume of information that must be evaluated.

AI and advanced analytical systems may help researchers organize, compare, and interpret this information more efficiently.

However, Bennett believes technology is most useful when incorporated into a disciplined analytical process.

Models and algorithms may identify correlations or patterns, but investment decisions still require an understanding of economic context, risk, market structure, and the limitations of available data.

The combination of human judgment, quantitative research, and advanced technology may therefore become an increasingly important part of modern investment analysis.

A Long-Term Perspective

Richard Bennett’s investment philosophy also emphasizes the importance of maintaining a long-term perspective.

Short-term market movements can often be influenced by sentiment, positioning, unexpected news, and temporary changes in liquidity. While these factors may create opportunities, they can also introduce significant noise into the investment process.

Bennett believes that long-term investment analysis should remain connected to broader fundamentals, including economic conditions, corporate performance, valuation, and sustainable market trends.

This does not mean ignoring short-term developments. Instead, it means evaluating them within a larger framework and determining whether they represent temporary market reactions or more meaningful structural changes.

A disciplined investment process can help investors remain focused on long-term objectives while continuing to adapt to evolving market conditions.

Richard Bennett and SUMMIT QUANT CAPITAL INC

Richard Bennett is associated with SUMMIT QUANT CAPITAL INC, where his professional focus includes financial markets research, quantitative investment analysis, risk management, and investment strategy.

The company maintains an interest in the continued evolution of quantitative finance, data analytics, financial technology, and artificial intelligence within investment research.

As markets become increasingly data-intensive and interconnected, SUMMIT QUANT CAPITAL INC continues to examine how traditional financial analysis and emerging technologies can be combined to support more structured and informed approaches to market research.

For Richard Bennett, the evolution of investment management is likely to involve a growing integration of financial theory, economic analysis, quantitative methods, and intelligent data technologies.

The objective is not simply to generate more information, but to develop research frameworks that can help investors interpret that information more effectively and make decisions within a disciplined risk-management process.

About SUMMIT QUANT CAPITAL INC

SUMMIT QUANT CAPITAL INC focuses on financial markets research, quantitative investment analysis, and data-driven investment methodologies.

Its areas of interest include global capital markets, macroeconomic trends, quantitative research, portfolio strategy, risk management, financial technology, and the evolving role of artificial intelligence in investment analysis.

Media Contact Details
Richard Bennett
Financial Markets Research & Investment Strategy
Email: Send Email
Website: summit-quant.com

Continue Reading

Uncategorized

UK Financial Ltd Announces Maya Preferred PRA Recognition as a Real World Asset on Etherscan and Confirms Buyback of 350 Million UK Financial Moonshot Tokens

London, UKUK Financial Ltd, creator of the Maya Preferred Project and the UK Financial Moonshot Token (UKFLMS), today announced another important milestone in the company’s eight-year blockchain journey. UK Financial Ltd recently designated $0.15 in gold backing per UKFLMS token while the token was trading at under one penny. UNDER $0.01 MARKET PRICE • $0.15 GOLD BACKING PER […]

Published

on

UK Financial Ltd, creator of the Maya Preferred Project and the UK Financial Moonshot Token (UKFLMS), today announced another important milestone in the company’s eight-year blockchain journey.

UK Financial Ltd recently designated $0.15 in gold backing per UKFLMS token while the token was trading at under one penny.

UNDER $0.01 MARKET PRICE • $0.15 GOLD BACKING PER TOKEN • ON-CHAIN TRANSPARENCY • REAL-WORLD-ASSET STRATEGY • BUILDING SINCE 2018

MAYA PREFERRED PRA RECOGNIZED AS A REAL WORLD ASSET

Maya Preferred PRA (MPRA) is now categorized on Etherscan under “Real World Assets.”

Etherscan, one of Ethereum’s primary blockchain explorers, displays the Real World Assets classification directly on the Maya Preferred PRA token page.

For UK Financial Ltd, the significance goes beyond a label.

The verified Ethereum smart contract for Maya Preferred PRA identifies MPRA as:

“Maya Preferred PRA – Preferred Class A Series Real World Asset Token (Gold & Silver Backed)”

The verified contract source further states that Maya Preferred PRA represents a Real World Asset backed by gold and silver and issued by UK Financial Ltd.

EIGHT YEARS OF BUILDING — NOW VISIBLE ON ETHEREUM

Maya Preferred was originally established as part of UK Financial Ltd’s effort to connect traditional real-world assets with blockchain technology.

What began years ago as an ambitious effort to bring gold, silver and other physical-asset structures into cryptocurrency has continued developing into a broader Real World Asset ecosystem.

Today, that history is increasingly visible directly on-chain.

MPRA Contract:
 0xEc1227BfB3e76d7a2A9bca24d9E98f68dE8bf808

Maximum Total Supply: 200,000,000 MPRA

CHAINLINK VERIFICATION — NINE TOKENS VERIFIED

UK Financial Ltd has made Chainlink verification a centerpiece of its latest blockchain milestone.

The company recently signed an agreement with Chainlink and subsequently verified supply information for all nine of its exchange-traded tokens, including Maya Preferred.

After nearly eight years, UK Financial Ltd says this verification demonstrates that it kept its commitment regarding the limited available token float.

Chainlink Verification Address:
 https://www.mayapreferred.io/CHAINLINK/MPRA/SUPPLY

UK FINANCIAL MOONSHOT TOKEN — 1 BILLION MAXIMUM SUPPLY

The UK Financial Moonshot Token carries a maximum supply of 1 billion tokens.

The company has already purchased more than 350 million of those tokens through buyback-style transactions directly on the Moonshot App.

UK Financial Ltd confirmed this 350 Million UKFLMS buyback has been executed, this was part of round one of two rounds and the Company has plans on purchasing as much of the remaining 1 billion tokens in round 2 as early as today.

UK Financial Ltd plans to continue purchasing from the remaining available float in the future, with the possibility of burning tokens acquired through those purchases.

FROM A COMPANY CLAIM TO VERIFIABLE BLOCKCHAIN INFORMATION

Most importantly, investors, researchers, exchanges and blockchain analysts do not have to rely solely on statements from UK Financial Ltd to examine how Maya Preferred PRA describes itself.

They can examine the verified smart-contract source directly on Ethereum.

MPRA’s verified contract source contains the Real World Asset designation and describes the token as backed by gold and silver. Etherscan’s token interface now additionally categorizes Maya Preferred PRA under Real World Assets.

That gives the public another independently visible layer through which to examine the Maya Preferred ecosystem.

JAMES DAHLKE: “THE BLOCKCHAIN IS BEGINNING TO TELL OUR STORY FOR US”

James Dahlke, President and CEO of UK Financial Ltd, stated:

“For eight years, we have said that Maya Preferred was built around real assets. Today, people don’t simply have to take our word for it. Go to Ethereum. Go to Etherscan. Look at Maya Preferred PRA. It is categorized under Real World Assets, and then go one step further and read our verified smart contract. It says exactly what Maya Preferred PRA was designed to represent — a Real World Asset token backed by gold and silver.”

Dahlke continued:

“That is where I believe cryptocurrency has to go. Don’t just tell people what something is. Put the structure on-chain. Give people the contract address. Give them the wallets. Give them the information and let them verify it themselves. The blockchain is beginning to tell our story for us.”

THE NEXT CHAPTER OF MAYA PREFERRED

The recognition comes as UK Financial Ltd continues expanding the infrastructure surrounding the Maya Preferred ecosystem, including its work involving Real World Assets, regulated-token architecture, blockchain transparency and ERC-3643 infrastructure.

Maya Preferred PRA remains the flagship Preferred Class token of the Maya Preferred Project and the foundation upon which a broader digital-asset ecosystem has been developed.

For UK Financial Ltd, the Etherscan RWA categorization represents something particularly important:

Visibility.

After years of development, the terminology UK Financial Ltd has used to describe Maya Preferred PRA can now be seen directly within one of Ethereum’s most widely used blockchain explorers.

VERIFY IT — DON’T JUST BELIEVE IT

UK Financial Ltd encourages the cryptocurrency community, exchanges, analysts and Maya Preferred holders to independently examine the Ethereum blockchain.

Token: Maya Preferred PRA
Symbol: MPRA
Blockchain: Ethereum
Classification displayed by Etherscan: Real World Assets
Maximum Total Supply: 200,000,000 MPRA
Contract: 0xEc1227BfB3e76d7a2A9bca24d9E98f68dE8bf808

The company believes the future of Real World Asset tokenization will ultimately be determined not by marketing claims, but by transparency, verifiability and infrastructure that can be independently examined on-chain.

UK FINANCIAL LTD

THE MAYA PREFERRED PROJECT

Eight Years of Building. Real Assets. Real Blockchain Infrastructure. Verifiable On-Chain.

FROM MEME TOKEN TO REAL-WORLD-ASSET INFRASTRUCTURE — UK FINANCIAL LTD IS WRITING ITS OWN HISTORY ON ETHEREUM.

#UKFinancialLtd #MayaPreferred #MPRA #UKFLMS #Chainlink #Ethereum #Etherscan #RWA #GoldBacked #RealWorldAssets

Media Contact Details
LJames Dahlke
Email: Send Email

Continue Reading

Uncategorized

Dallas, TX Employment Law Firm Announces Key Promotion, New Hires

Dallas, TXThe Devadoss Law Firm, P.L.L.C. is pleased to announce a new promotion within the firm, along with the addition of six new attorneys to its growing team. This continued growth and refinement helps support the firm’s mission of representing federal employees in complicated labor cases. First, the firm is proud to share that Meagan Brooks […]

Published

on

The Devadoss Law Firm, P.L.L.C. is pleased to announce a new promotion within the firm, along with the addition of six new attorneys to its growing team. This continued growth and refinement helps support the firm’s mission of representing federal employees in complicated labor cases.

First, the firm is proud to share that Meagan Brooks has been promoted to Operations Office Manager. In this role, she will work directly under the Director of Accounts and Operations and will be involved in the daily operations of the firm across all areas. Her promotion speaks to the trust the firm places in her leadership and her contributions to the team.

The firm has also hired five associates who will support its litigation team. These new associates are Hannah Highland, Justin Yao, Chloe Marshall, Tatum Cooper, and Liam Tomson. Each brings valuable experience and skill to the firm as it continues to represent federal employees in high-stakes legal disputes.

In addition, the firm has hired Ashley Hales as an OWCP and OPM associate for its transactional team. Her focus will be on cases involving the Office of Workers’ Compensation Programs and the Office of Personnel Management.

For more than 20 years, The Devadoss Law Firm, P.L.L.C. has exclusively represented federal government employees. In that time, the firm has handled more than 5,000 federal sector employment cases. These new additions reflect the firm’s commitment to serving federal employees nationwide, expanding the firm’s breadth of legal knowledge and experience.

About The Devadoss Law Firm, P.L.L.C.

At The Devadoss Law Firm, P.L.L.C., we represent federal employees across the country in investigations, disciplinary actions, workers’ compensation claims, and other employment issues. From our offices in Washington, D.C., Atlanta, and Dallas, we are positioned to serve federal employees no matter where they are stationed. To learn more, visit https://www.fedemploymentlaw.com/ or call 888-351-0424 to schedule a free consultation. 

Media Contact Details
Brian Wildman
Email: Send Email
Website: www.ovclawyermarketing.com

Continue Reading

Trending